Outranked only by skin cancer, prostate cancer is the second most common cancer in men in the U.S. Although one in every ...

Continuing PSA screening in older men is common practice but not recommended, highlighting the need for clearer guidance.

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have validated a test that can accurately predict which ...

The likelihood of developing prostate cancer increases significantly with age, particularly after the age of 50 ...

Kidney stones and gallstones may increase the risk for prostate cancer, which could have implications for disease monitoring and prevention in specific populations. Patients with kidney stones or ...

The American Cancer Society recommends that Black men discuss screening with their health care provider at age 45; the Prostate Cancer Foundation recommends prostate-specific antigen testing beginning ...

Thousands of men in Sheffield will be offered the opportunity to take part in a new £4.5 million prostate screening trial ...

Elevated circulating tumor DNA (ctDNA) fraction and tumor suppressor gene loss are associated with worse prognosis in patients with prostate cancer liver metastases (PCLM), accord ...

For instance, a patient with low prognostic risk would likely ... Short-term ADT Biomarker (for men at intermediate risk for prostate cancer, a positive result indicates the patient will likely ...